Skip to main content

Table 1 Significant differences in clinical features among the four groups

From: Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia

  NC Hhcy Hhcy + ATH ATH P-value
Males/females 10/10 14/11 20/10 15/10 0.682
Age (years) 48.00 ± 4.44 47.16 ± 5.50 49.00 ± 5.47 46.92 ± 5.20 0.445
BMI (kg/m2) 24.13 ± 2.84 23.47 ± 2.30 25.03 ± 3.58 23.13 ± 2.68 0.080
TC (mmol/l) 3.94 ± 0.79 4.60 ± 0.99 5.56 ± 1.26 4.34 ± 1.04 <0.001**
TG (mmol/l) 1.12 ± 0.07 1.37 ± 0.04 1.45 ± 0.09 1.41 ± 0.11 0.001**
HDL-c (mmol/l) 1.43 ± 0.55 1.58 ± 0.63 1.59 ± 0.57 1.82 ± 0.66 0.176
LDL-c (mmol/l) 2.74 ± 0.91 3.46 ± 0.88 3.36 ± 0.93 3.18 ± 0.81 0.043*
ApoA(g/l) 1.32 ± 0.22 1.39 ± 0.27 1.39 ± 0.41 1.47 ± 0.31 0.480
ApoA/B 1.51 ± 0.42 1.57 ± 0.5 1.42 ± 0.45 1.53 ± 0.43 0.671
ApoB(g/l) 0.96 ± 0.25 0.93 ± 0.19 1.01 ± 0.28 1.01 ± 0.31 0.580
FBG (mmol/l) 5.06 ± 0.74 4.93 ± 0.55 5.07 ± 0.5 4.93 ± 0.59 0.722
ALT (U/l) 22.8 ± 13.02 19.8 ± 10.17 27.0 ± 12.8 20.48 ± 10.86 0.100
AST (U/l) 20.25 ± 10.17 20.84 ± 10.02 20.57 ± 12.36 21.2 ± 10.73 0.993
UA (umol/l) 255.65 ± 63.2 302.96 ± 105.9 258.9 ± 114.2 224.12 ± 106.1 0.795
Cre (umol/l) 73.68 ± 22.12 75.72 ± 24.12 71.3 ± 16.16 69.88 ± 19.84 0.754
Hcy (umol/l) 9.53 ± 2.99 19.07 ± 2.85 21.90 ± 4.69 11.16 ± 2.43 < 0.001**
  1. Continuous and categorical variables data were expressed as mean ± SEM. The statistical P value was generated by the one-way ANOVA test or Kruskal-Wallis test. χ2 test was employed to compare gender distribution. *P < 0.05 or **P < 0.001 was considered significant